• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Improving Affordability in Dermatology: Cost Savings in Mark Cuban Cost Plus Drug Company Versus GoodRx.提高皮肤科医疗费用的可承受性：马克·库班成本加成制药公司与GoodRx的成本节约情况
JMIR Dermatol. 2024 Dec 13;7:e64300. doi: 10.2196/64300.
2
Potential Cost-Saving Model Utilizing Mark Cuban Cost Plus Drug Company for Purchasing Common Otolaryngology Medications.利用马克·库班成本加成制药公司采购常见耳鼻喉科药物的潜在成本节约模型。
Otolaryngol Head Neck Surg. 2025 Feb;172(2):693-696. doi: 10.1002/ohn.1058. Epub 2024 Nov 19.
3
Patient-Level Savings on Generic Drugs Through the Mark Cuban Cost Plus Drug Company.通过马克·库班成本加成制药公司实现的患者层面通用药物节省费用。
JAMA Health Forum. 2024 Jun 7;5(6):e241468. doi: 10.1001/jamahealthforum.2024.1468.
4
Drug Pricing Stewardship from Mark Cuban's Cost Plus Generic Drug Program.从马克·库班的成本加成仿制药计划看药品定价管理
Pharmacoeconomics. 2024 Nov;42(11):1279-1286. doi: 10.1007/s40273-024-01426-3. Epub 2024 Aug 21.
5
A cost analysis of medications prescribed by vascular surgeons.血管外科医生所开药物的成本分析。
J Vasc Surg. 2025 Jan;81(1):235-242. doi: 10.1016/j.jvs.2024.08.022. Epub 2024 Aug 22.
6
Comparing prescription drug saving platforms for dermatology: A cost analysis of Mark Cuban Cost Plus Drugs, GoodRx, and Amazon RxPass.
J Am Acad Dermatol. 2025 May;92(5):1138-1141. doi: 10.1016/j.jaad.2025.01.045. Epub 2025 Jan 23.
7
Dissecting drug pricing: Supply chain, market, and nonmarket trends impacting clinical dermatology.剖析药品定价：影响临床皮肤科的供应链、市场及非市场趋势
J Am Acad Dermatol. 2020 Aug;83(2):691-699. doi: 10.1016/j.jaad.2020.04.063. Epub 2020 Apr 21.
8
Online Tools to Decrease Out-of-Pocket Prescription Costs for Patients: A Practical Guide for Urologists.在线工具可降低患者自付处方药费用：泌尿科医生实用指南。
Urol Pract. 2024 May;11(3):454-460. doi: 10.1097/UPJ.0000000000000544. Epub 2024 Apr 19.
9
Potential Medicare Part D Savings on Generic Drugs From the Mark Cuban Cost Plus Drug Company.马克·库班成本加成制药公司可能为医疗保险D部分带来的仿制药成本节省。
Ann Intern Med. 2022 Jul;175(7):1053-1055. doi: 10.7326/M22-0756. Epub 2022 Jun 21.
10
Urological Drug Price Stewardship: Potential Cost Savings Based on the Mark Cuban Cost Plus Drug Company Model.泌尿外科药物价格管理：基于马克·库班成本加成制药公司模式的潜在成本节约
J Urol. 2023 Feb;209(2):309-311. doi: 10.1097/JU.0000000000003083. Epub 2022 Nov 22.

本文引用的文献

1
Generic cardiology drug prices: the potential benefits of the Marc Cuban cost plus drug company model.通用心脏病药物价格：马克·库班成本加成制药公司模式的潜在益处
Front Pharmacol. 2023 Aug 22;14:1179253. doi: 10.3389/fphar.2023.1179253. eCollection 2023.
2
Analysis of Prescribing Practices in the Dermatology Outpatient Department of a Tertiary Care Teaching Hospital.三级护理教学医院皮肤科门诊处方实践分析
Cureus. 2023 Apr 20;15(4):e37910. doi: 10.7759/cureus.37910. eCollection 2023 Apr.
3
Delayed medical care due to transportation barriers among US children with atopic dermatitis.由于交通障碍，美国患有特应性皮炎的儿童延迟了医疗护理。
Pediatr Dermatol. 2022 Nov;39(6):927-930. doi: 10.1111/pde.15124. Epub 2022 Aug 25.
4
Price discrepancies among mobile medication applications for common dermatologic prescriptions: Observational cost analysis.常见皮肤科处方的移动用药应用程序之间的价格差异：观察性成本分析。
J Am Acad Dermatol. 2017 Dec;77(6):1181-1182. doi: 10.1016/j.jaad.2017.07.017.
5
Economic Evaluation of Text-Messaging and Smartphone-Based Interventions to Improve Medication Adherence in Adolescents with Chronic Health Conditions: A Systematic Review.基于短信和智能手机的干预措施对改善慢性病青少年药物依从性的经济学评价：一项系统综述。
JMIR Mhealth Uhealth. 2016 Oct 25;4(4):e121. doi: 10.2196/mhealth.6425.
6
Health outcomes in patients using no-prescription online pharmacies to purchase prescription drugs.使用非处方在线药房购买处方药的患者的健康状况。
J Med Internet Res. 2012 Dec 6;14(6):e174. doi: 10.2196/jmir.2236.

提高皮肤科医疗费用的可承受性：马克·库班成本加成制药公司与GoodRx的成本节约情况

Improving Affordability in Dermatology: Cost Savings in Mark Cuban Cost Plus Drug Company Versus GoodRx.

作者信息

Youn Christopher G, Kim Joo Yeon, Yang Vivian B, Bae Gordon H

机构信息

Department of Dermatology, Stanford University School of Dermatology, 450 Broadway, Pavilion C, 2nd Floor, Redwood City, CA, 94063, United States, 1 650-721-7190.

School of Medicine, University of California, San Francisco School of Medicine, San Francisco, CA, United States.

出版信息

JMIR Dermatol. 2024 Dec 13;7:e64300. doi: 10.2196/64300.

DOI:10.2196/64300
PMID:39671560
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11661688/
Abstract

This observational cost analysis was conducted to assess the efficacy of the Mark Cuban Cost Plus Drug Company (CostPlus) relative to GoodRx and found that CostPlus has significant potential to improve the financial burden of prescription medications within dermatology.

摘要

这项观察性成本分析旨在评估马克·库班成本加成制药公司（CostPlus）相对于GoodRx的疗效，发现CostPlus在减轻皮肤科处方药的经济负担方面具有巨大潜力。